Search research articles
Contact Us
Filters
Showing results (41-50 of 119) with videos related to
Page
of 12
Sort By:
Journal of Neuropathology and Experimental Neurology
|
November 24, 1998
Glial tumors in the MNU rat model: induction of pure and mixed gliomas that do not require typical missense mutations of p53
E J Rushing, M L Watson, S C Schold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1991
Clinical application of PET for the evaluation of brain tumors
R E Coleman, J M Hoffman, M W Hanson, et al.
Cancer Research
|
May 1, 1996
Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU
S C Schold, D M Kokkinakis, J L Rudy, et al.
Cancer Research
|
November 1, 1984
In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma
H S Friedman, S C Schold, L H Muhlbaier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2001
Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide
D M Kokkinakis, D B Bocangel, S C Schold, et al.
Neurology
|
March 1, 1991
Sagittal sinus thrombosis and leptomeningeal medulloblastoma
M T Brown, H S Friedman, W J Oakes, et al.
Cancer
|
April 15, 1996
Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. A case report
H M Fathallah-Shaykh, C Zimmerman, H Morgan, et al.
British Journal of Cancer
|
January 1, 1997
Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells
D M Kokkinakis, M A von Wronski, T H Vuong, et al.
Neurosurgery
|
August 1, 1988
Transient late magnetic resonance imaging changes suggesting progression of brain stem glioma: implications for entry criteria for phase II trials
D C Longee, H S Friedman, W T Djang, et al.
Cancer Research
|
January 15, 1996
In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor
J M Piepmeier, N Rabidou, S C Schold, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 119) with videos related to
Sort By:
Page
of 12
Journal of Neuropathology and Experimental Neurology
|
November 24, 1998
Glial tumors in the MNU rat model: induction of pure and mixed gliomas that do not require typical missense mutations of p53
E J Rushing, M L Watson, S C Schold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1991
Clinical application of PET for the evaluation of brain tumors
R E Coleman, J M Hoffman, M W Hanson, et al.
Cancer Research
|
May 1, 1996
Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU
S C Schold, D M Kokkinakis, J L Rudy, et al.
Cancer Research
|
November 1, 1984
In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma
H S Friedman, S C Schold, L H Muhlbaier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2001
Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide
D M Kokkinakis, D B Bocangel, S C Schold, et al.
Neurology
|
March 1, 1991
Sagittal sinus thrombosis and leptomeningeal medulloblastoma
M T Brown, H S Friedman, W J Oakes, et al.
Cancer
|
April 15, 1996
Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. A case report
H M Fathallah-Shaykh, C Zimmerman, H Morgan, et al.
British Journal of Cancer
|
January 1, 1997
Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells
D M Kokkinakis, M A von Wronski, T H Vuong, et al.
Neurosurgery
|
August 1, 1988
Transient late magnetic resonance imaging changes suggesting progression of brain stem glioma: implications for entry criteria for phase II trials
D C Longee, H S Friedman, W T Djang, et al.
Cancer Research
|
January 15, 1996
In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor
J M Piepmeier, N Rabidou, S C Schold, et al.
Page
of 12